Welcome to Acrosian
The Biometrics CRO
for the AI era.
Integrated data management, biostatistics, statistical programming, and medical writing — delivered by senior biometrics experts with two decades of CRO scale experience and a validated, audit-ready framework engineered from day one, with AI augmentation being progressively built into every function.
Zero layoffs across
two decades
of scale
From the founding team that scaled a 600-person biometrics CRO to a private equity exit.
Flag data anomalies before database lock
20yrs
Building biometrics at scale
4
Integrated biometrics functions
3
Continents of operations
1exit
To private equity
0
Layoffs across two decades
One quality system.
Audit-ready.
Zero layoffs. 20 years.
Senior-led.
AI-augmented.
Validation-gated.
What We Do
One integrated partner for the four functions with the greatest impact on trial timelines and submission quality.
Every function is built on the same integrated delivery model, with AI augmentation being progressively added under a unified GxP validation framework.
01
Clinical Data Management
Protocol-aligned database design, data cleaning, query management, and database lock readiness — under senior data manager oversight.
02
Biostatistics
SAP development, sample size and power calculations, randomization, interim analyses, and adaptive design strategy — under senior statistician oversight.
03
Statistical Programming
SDTM and ADaM development, TLF generation, submission-ready CDISC outputs, and define.xml — under senior programmer oversight.
04
Medical Writing
Protocols, clinical study reports (CSRs), briefing books, and submission-ready regulatory documents — under senior medical writer oversight.
One point of accountability.
One quality system. One audit trail.
The AI Advantage
AI changes the ratio of senior judgment to repetitive labor.
We designed Acrosian around AI from day one. There is no legacy delivery model to retrofit. There is no organizational complexity to overcome. There is the work done by the people best equipped to do it in the era we are now in.
Senior judgment is the constant. Every program is owned by a senior expert with the authority and experience to make decisions in real time — not junior staff supervised at a distance.
AI is the leverage. Validated tooling compresses the repetitive work — data cleaning, programming, drafting, consistency review — without replacing the expertise behind it.
Validation is the gate. No AI capability reaches client delivery until it meets our GxP validation standard, with audit-ready documentation from program start.
The AI Advantage
AI changes the ratio of senior judgment to repetitive labor.
We designed the firm around AI from day one. There is no legacy delivery model to retrofit. There is no organizational anxiety to manage. There is the work, done by the people best equipped to do it in the era we are now in.
Two decades ago
Built for the internet era
Our founding team built a biometrics CRO on the leverage that the internet era made possible.
20 years of scale
600+ professionals,
18+ therapeutic areas
Supported clinical studies across every economic cycle and successfully exited to Summit Partners private equity.
Now
Started fresh as
an AI-native CRO
Rather than building on legacy systems designed for a different era, we started fresh — an AI-native biometrics CRO built for the future of clinical research. That company is Acrosian LLC.